Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,893 | -5,569 | -12,913 | -12,125 | -4,202 |
| Depreciation Amortization | 178 | 7 | 4 | 2 | 1 |
| Accounts receivable | 62 | -1,111 | -273 | N/A | 197 |
| Accounts payable and accrued liabilities | 503 | 393 | -491 | -138 | -152 |
| Other Working Capital | 340 | -540 | 27 | 269 | 284 |
| Other Operating Activity | -771 | -1,660 | 5,019 | 5,730 | 564 |
| Operating Cash Flow | $-5,581 | $-8,480 | $-8,627 | $-6,262 | $-3,308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,511 | 1,967 | 4,411 | -7,899 | N/A |
| PPE Investments | -11 | -16 | -13 | -10 | -9 |
| Net Acquisitions | N/A | N/A | -1,732 | N/A | N/A |
| Purchase Of Investment | -2,100 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 151 | 93 | 106 | 138 | 0 |
| Investing Cash Flow | $-449 | $2,044 | $2,772 | $-7,771 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -130 | N/A | -439 |
| Common Stock Issued | 6,043 | 8,665 | 3,526 | 12,325 | 15,134 |
| Other Financing Activity | -810 | -877 | -401 | -2,039 | -2,063 |
| Financing Cash Flow | $5,233 | $7,788 | $2,995 | $10,286 | $12,632 |
| Exchange Rate Effect | 19 | -136 | 49 | -53 | -70 |
| Beginning Cash Position | 5,163 | 3,947 | 6,758 | 10,558 | 1,313 |
| End Cash Position | 4,385 | 5,163 | 3,947 | 6,758 | 10,558 |
| Net Cash Flow | $-778 | $1,216 | $-2,811 | $-3,800 | $9,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,581 | -8,480 | -8,627 | -6,262 | -3,308 |
| Capital Expenditure | -11 | -16 | -13 | -10 | -9 |
| Free Cash Flow | -5,592 | -8,496 | -8,640 | -6,272 | -3,317 |